Effects of Dietary Eicosapentaenoic Acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Bertrand, Chantal ^a,b   Pignalosa, Angelica ^c   Wanecq, Estelle ^a,b   Rancoule, Chloé ^a,b   Batut, Aurélie ^a,b   Deleruyelle, Simon ^a,b   Lionetti, Lillà ^c   Valet, Philippe ^a,b   Castan Laurell, Isabelle ^a,b  

^a INSERM   (France)

^b Université de Toulouse   (France)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; APELIN; APELIN RECEPTOR; GLUCOSE; ICOSAPENTAENOIC ACID; LEPTIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT MASS; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULINEMIA; LIPID COMPOSITION; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; MUSCLE CELL; MUSCLE METABOLISM; NONHUMAN; OBESITY; SKELETAL MUSCLE; SOLEUS MUSCLE; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; CELL LINE; DIETARY FATS; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY;

EID: 84892400720     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078874     Document Type: Article

References (41)

1. Kopecky J, Rossmeisl M, Flachs P, Kuda O, Brauner P, et al. (2009) n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 68:361-369.
2. Delarue J, LeFoll C, Corporeau C, Lucas D (2004) N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev 44:289-299.
3. Siriwardhana N, Kalupahana NS, Moustaid-Moussa N (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Adv Food Nutr Res 65:211-222.
4. Fedor D, Kelley DS (2009) Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 12:138-146.
5. Poudyal H, Panchal SK, Diwan V, Brown L (2011) Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 50:372-387.
6. Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, et al. (2010) Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 140:1915-1922.
7. Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, et al. (2010) Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 59:2495-2504.
8. Kasbi Chadli F, Andre A, Prieur X, Loirand G, Meynier A, et al. (2011) n-3 PUFA prevent metabolic disturbances associated with obesity and improve endothelial function in golden Syrian hamsters fed with a high-fat diet. Br J Nutr:1-11.
9. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, et al. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23:1946-1957.
10. Perez-Matute P, Marti A, Martinez JA, Fernandez-Otero MP, Stanhope KL, et al. (2005) Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: role of glucose metabolism. Am J Physiol Regul Integr Comp Physiol 288:R1682-1688.
11. Murata M, Kaji H, Takahashi Y, Iida K, Mizuno I, et al. (2000) Stimulation by eicosapentaenoic acids of leptin mRNA expression and its secretion in mouse 3T3-L1 adipocytes in vitro. Biochem Biophys Res Commun 270:343-348.
12. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, et al. (2001) Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 42:743-50.
13. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, et al. (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49:394-397.
14. Tishinsky JM, Ma DW, Robinson LE (2011) Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARgamma-dependent manner in human adipocytes. Obesity (Silver Spring) 19:262-268.
15. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, et al. (2008) Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8:437-445.
16. Lorente-Cebrian S, Bustos M, Marti A, Martinez JA, Moreno-Aliaga MJ (2010) Eicosapentaenoic acid up-regulates apelin secretion and gene expression in 3T3-L1 adipocytes. Mol Nutr Food Res 54 Suppl 1:S104-11.
17. Perez-Echarri N, Perez-Matute P, Marcos-Gomez B, Martinez JA, Moreno-Aliaga MJ (2009) Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats. Br J Nutr 101:1059-1067.
18. O'Carroll AM, Selby TL, Palkovits M, Lolait SJ (2000) Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492:72-80.
19. Dray C, Debard C, Jager J, Disse E, Daviaud D, et al. (2010) Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab 298:E1161-1169.
20. Attane C, Foussal C, Le Gonidec S, Benani A, Daviaud D, et al. (2012) Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 61:310-320.
21. Yamamoto T, Habata Y, Matsumoto Y, Yasuhara Y, Hashimoto T, et al. (2011) Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle. Biochim Biophys Acta 1810:853-862.
22. Lillington JM, Trafford DJ, Makin HL (1981) A rapid and simple method for the esterification of fatty acids and steroid carboxylic acids prior to gas-liquid chromatography. Clin Chim Acta 111:91-98.
23. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
24. Figueras M, Olivan M, Busquets S, Lopez-Soriano FJ, Argiles JM (2011) Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity (Silver Spring) 19:362-369.
25. Jones TE, Baar K, Ojuka E, Chen M, Holloszy JO (2003) Exercise induces an increase in muscle UCP3 as a component of the increase in mitochondrial biogenesis. Am J Physiol Endocrinol Metab 284:E96-101.
26. Mazzucotelli A, Ribet C, Castan-Laurell I, Daviaud D, Guigné C, et al. (2008) The transcriptional co-activator PGC1alpha up regulates apelin in human and mouse adipocytes. Regul Pept 150:33-37.
27. Calder PC (2012) Mechanisms of action of (n-3) fatty acids. J Nutr 142: 592S-599S.
28. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, et al. (2005) Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146:1764-1771.
29. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, et al. (2006) TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB J 20: 1528-30.
30. Warensjo E, Ohrvall M, Vessby B (2006) Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 16:128-136.
31. Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, et al. (2012) Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol 18:5839-5847.
32. Jump DB (2008) N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19:242-247.
33. Dentin R, Denechaud PD, Benhamed F, Girard J, Postic C (2006) Hepatic gene regulation by glucose and polyunsaturated fatty acids: a role for ChREBP. J Nutr 136:1145-1149.
34. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, et al. (2009) Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58: 550-558.
35. Bezaire V, Spriet LL, Campbell S, Sabet N, Gerrits M, et al. (2005) Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation. FASEB J 19:977-979.
36. Pope GR, Roberts EM, Lolait SJ, O'Carroll AM (2012) Central and peripheral apelin receptor distribution in the mouse: species differences with rat. Peptides 33: 139-148.
37. Fan C, Liu X, Shen W, Deckelbaum RJ, Qi K (2011) The Regulation of Leptin, Leptin Receptor and Pro-opiomelanocortin Expression by N-3 PUFAs in Diet-Induced Obese Mice Is Not Related to the Methylation of Their Promoters. Nutr Metab (Lond) 8:31.
38. Wang XL, Tao Y, Lu Q, Jiang YR (2012) Apelin supports primary rat retinal müller cells under chemical hypoxia and glucose deprivation. Peptides 33: 298-306.
39. Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W (2010) Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. J Thorac Oncol 8: 1120-1129.
40. Ronkainen VP, Ronkainen JJ, Hänninen SL, Leskinen H, Ruas JL, et al. (2007) Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 21: 1821-1830.
41. Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, et al. (2013) Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial. J Natl Cancer Inst. 105(15): 1132-1141.